Joel Gelfand, MD, MSCE, FAAD
Speaker(s)
Faculty
James J Leyden Professor of Dermatology and of Epidemiology; Director, Center for Clinical Sciences in Dermatology; Director, Psoriasis and Phototherapy Treatment Center; University of Pennsylvania Perelman School of Medicine; Philadelphia, PA
Disclosure
Grant/Research Support: BMS, Lilly
Consultant: Abbvie, Arcutis, Alumis, Arnold Palmer Law, Artax (DSMB), Boehringer Ingelheim, FIDE, GSK, Inmagene (DSMB), Johnson and Johnson,
Lilly, Leo, Moonlake (DSMB), Neuroderm (DSMB), Oliver Law, Pfizer, Oruka, Inc, and Teva (DSMB)